Drug Type Biosimilar, Monoclonal antibody |
Synonyms Tocilizumab Biosimilar (Jiangsu Pacific Meinok Biopharmaceutical Co., Ltd.), 托珠单抗生物类似药(Jiangsu Pacific Meinok Biopharmaceutical Co., Ltd.) |
Target |
Action antagonists |
Mechanism IL-6RA antagonists(Interleukin-6 receptor alpha subunit antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | China | 07 Nov 2023 |